TAAT® Obtains Registered Trademark Status in Eight Global

LAS VEGAS and VANCOUVER, British Columbia, March 25, 2022 (GLOBE NEWSWIRE) — TAAT® GLOBAL ALTERNATIVES INC. (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) (the “Company” or “TAAT®”) is pleased to announce that its trademark applications for the TAAT® brand name have been finalized as “registered” trademarks in eight global markets, including the United States, where TAAT® Original, Smoothand Menthol are now sold in at least 2,500 stores. Beginning in 2021, the company began seeking trademark protection in several international markets as part of its plan to expand throughout the global tobacco industry. As of the fourth week of March 2022, the TAAT® brand name is now a registered trademark in the following global markets:

Marlet Population1 Smoking rate
united states of america 329.4 million 12.5%2
European Union (27 members) 447.8 million 18.4%3
Australia 25.6 million 11.6%4
New Zealand 5.08 million 13.4%5
Philippines 109.5 million 18.7%6
Israel 9.2 million 19.8%7
India 1.38 billion 29%8
Mexico 128.9 million 16.4%9

The applicability of the various intellectual properties comprising the TAAT® brand, as well as the product and its trade dress, has become increasingly important to the Company as it continues to grow its footprint. The brand attributes of older tobacco products such as cigarettes appear to have become increasingly irrelevant in some markets in light of regulations mandating “plain packaging” with minimal branding elements permitted on packs and packaging. boxes. As a tobacco-free product, TAAT® is generally exempt from these regulations and may display its logo, messages and the colors corresponding to each TAAT® flavor as part of its point-of-sale presence. As such, brand features such as the TAAT® name are a crucial part of the product’s public appearance, and trademark protection in the United States as well as seven other global markets could benefit growth. long term of the company.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/6ec527c1-78d8-4ecb-b762-d91efb8bdb7a

Readers using news aggregation services may not be able to view the above media. Please access SEDAR or Investor Relations section of the Company’s website for a version of this press release containing all published media.

TAAT® Founder, Joe Deighan, commented, “Building a strong IP portfolio for a product and brand is a marathon, not a race, given standard approval timelines for reviewing and processing requests for things such as trademarks. In the CPG industry, brands are extremely important not only for the long-term profitability of a given brand, but also for consumer protection. In markets like the UK, counterfeit cigarettes are a pervasive problem that ultimately harms individual smokers the most with cigarettes of unknown quality sold under well-known brand names.ten. Through legal mechanisms such as trademarks, tobacco companies like TAAT® are able to fend off the seemingly inevitable counterfeits of their products that may come to market. Additionally, trademarks can provide broader protection for the brand beyond just the smoking product in categories such as merchandise. It is a significant milestone for us to have secured a trademark on the TAAT® brand in the United States and several markets that we plan to enter in the near future, and we look forward to enjoying trademark protection. that these trademarks offer. we. ”


1 – https://data.worldbank.org/indicator/SP.POP.TOTL

2 – https://www.cdc.gov/tobacco/data_statistics/fact_sheets/adult_data/cig_smoking/index.htm

3 – https://ec.europa.eu/eurostat/web/products-eurostat-news/-/edn-20211112-1

4 – https://www.aihw.gov.au/reports/australias-health/tobacco-smoking

5 – https://www.health.govt.nz/our-work/preventative-health-wellness/tobacco-control/smokefree-aotearoa-2025-action-plan/history-smokefree-aotearoa-2025

6 – https://psa.gov.ph/press-releases/id/165209

7 – https://www.health.gov.il/English/Topics/KHealth/smoking/Pages/SmokingRatesInIsrael.aspx

8 – https://www.who.int/india/health-topics/tobacco

9 – https://www.tobaccofreekids.org/problem/toll-global/latin-america/mexico

ten – https://www.bbc.com/news/business-47004388

On behalf of the Company’s Board of Directors,


Setti Coscarella

Setti Coscarella, CEO and Director

For more information, please contact:

TAAT® Investor Relations
1-833-TAAT-USA (1-833-822-8872)
[email protected]


About TAAT® Global Alternatives Inc.

The Company has developed TAAT®, which is a tobacco-free and nicotine-free alternative to traditional cigarettes offered in “Original”, “Smooth” and “Menthol” varieties. The base material of TAAT® is Beyond Tobacco™, a proprietary blend that undergoes a patent-pending refinement technique that causes its scent and taste to resemble tobacco. Under the direction of management with the “Big Tobacco” pedigree, TAAT® was first launched in the United States in the fourth quarter of 2020 as the company seeks to position itself on the 812 billion dollars1 the global tobacco industry.

For more information, please visit http://taatglobal.com.

The references

1 Statista: Consumer Markets – Tobacco Products

Forward-looking statements

This press release contains “forward-looking information” within the meaning of applicable Canadian securities laws. Often, but not always, forward-looking information and information can be identified by the use of words such as “anticipates”, “expects” or “does not expect”, “is expected”, “estimates “, “intends to”, “anticipates” or “does not anticipate”, or “believes”, or variations of these words and expressions or declare that certain actions, events or results “may”, “might” , “would”, “could” or “will” take, occur or be realized. The forward-looking information contained in this press release includes statements regarding the anticipated performance of TAAT® in the tobacco industry, in addition to following: the potential results and benefits of registration of the TAAT® trademark in the eight markets mentioned in the press release, potential issuance of in-demand trademarks in other markets Forward-looking information reflects management’s current expectations regarding the base of the i’s information currently available and is subject to a number of risks and uncertainties that may cause actual results to differ materially from those discussed in the forward-looking information. Although the Company believes that the assumptions and factors used in the preparation of forward-looking information are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur within the time periods disclosed or not. at all. Factors that could cause actual results or events to differ materially from current expectations include: (i) adverse market conditions; (ii) changes in the growth and size of tobacco markets; and (iii) other factors beyond the Company’s control. The Company operates in a rapidly changing environment. New risk factors emerge from time to time, and it is impossible for the management of the Company to predict all risk factors, nor can the Company assess the impact of all factors on the business of the Company. Company or the extent to which any factor, or combination of factors, could cause actual results to differ from those contained in the forward-looking information. The forward-looking information included in this press release is made as of the date of this press release, and the Company expressly disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. , except as required by applicable law.

The statements in this press release have not been evaluated by Health Canada or the United States Food and Drug Administration. As each individual is different, the benefits, if any, of taking the Company’s products will vary from person to person. No claim or warranty can be made as to the effects of the Company’s products on the health and well-being of any individual. The Company’s products are not intended to diagnose, treat, cure or prevent any disease.

This press release may contain brand names of third-party entities (or their respective offerings with brand names) generally in reference to (i) the Company’s relationships with the third-party entities mentioned in this press release and/or (ii ) customers/suppliers/service providers whose relationship with the Company is/are mentioned in this press release. All rights in these marks are reserved by their respective owners or licensees.

Statement Regarding Third-Party Investor Relations Firms

Information about the investor relations firms retained by TAAT® Global Alternatives Inc. can be found under the company profile on http://sedar.com.

About Margaret Shaw

Check Also

Top FDA tobacco official resigns to take job at Philip Morris International

OOn July 26, Matthew Holman, director of the Food and Drug Administration’s Center for Tobacco …